is glp 1 better than tirzepatide vs. Semaglutide: What You Should Know Tirzepatide vs Semaglutide for Weight

National Library of Medicine) Monash University

Zepbound received approval in November 2023 for chronic weight management in adults with obesity or overweight plus a weight-related condition, and in December 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity

Patients involved in comprehensive lifestyle programs often maintain their weight loss even after stopping treatment

The medication comes in a pre-filled pen that is easy to use, allowing individuals to self-administer the injections at home

The database also lacks patient-level covariates such as baseline renal function, diabetes severity, medication dose, duration of exposure, and comorbid conditionsall of which are essential for causal inference

The Precision Peptide Genetic Test offered by PlexusDx analyzes variants in peptide pathway genes that may help provide context for baseline metabolic characteristics